Minocycline and matrix metalloproteinase inhibition in acute intracerebral hemorrhage: a pilot study

ConclusionsHigh‐dose intravenous minocycline can be safely administered to patients with ICH. Larger randomized clinical trials evaluating the efficacy of minocycline and MMP‐9 inhibition in ICH patients are required.

Source: European Journal of Neurology - September 20, 2017 Category: Neurology Authors: J. J. Chang, M. Kim ‐Tenser, B. A. Emanuel, G. M. Jones, K. Chapple, A. Alikhani, N. Sanossian, W. J. Mack, G. Tsivgoulis, A. V. Alexandrov, T. Pourmotabbed Tags: Original Article Source Type: research